Debbie Zittema

Dose-Titrated Vasopressin V2 Receptor Antagonist Improves Renoprotection in a Mouse Model for Autosomal Dominant Polycystic Kidney Disease

R. Gansevoort, D. Peters, Emile de Heer, 2016, American Journal of Nephrology.

Vasopressin, copeptin, and renal concentrating capacity in patients with autosomal dominant polycystic kidney disease without renal impairment.

R. Gansevoort, E. Meijer, P. D. de Jong, 2012, Clinical journal of the American Society of Nephrology : CJASN.

University of Groningen Urine Concentrating Capacity , Vasopressin and Copeptin in ADPKD and IgA Nephropathy Patients with Renal Impairment

S. Bakker, R. Gansevoort, Debbie Zittema, 2017 .

Kidney function and plasma copeptin levels in healthy kidney donors and autosomal dominant polycystic kidney disease patients.

G. Navis, S. Bakker, R. Gansevoort, 2014, American Society of Nephrology. Clinical Journal.

Copeptin, a surrogate marker for arginine vasopressin, is associated with disease severity and progression in IgA nephropathy patients.

J. Wetzels, S. Bakker, R. Gansevoort, 2017, Nephrology, Dialysis and Transplantation.

Use of the Urine-to-Plasma Urea Ratio to Predict ADPKD Progression.

R. Gansevoort, E. Meijer, Debbie Zittema, 2021, Clinical journal of the American Society of Nephrology : CJASN.

The Effect of Renal Function and Hemodialysis Treatment on Plasma Vasopressin and Copeptin Levels

R. Gansevoort, Debbie Zittema, N. Casteleijn, 2017, Kidney international reports.

Dialysis Hypotension: A Role for Inadequate Increase in Arginine Vasopressin Levels? A Systematic Literature Review and Meta-Analysis

R. Gansevoort, P. D. de Jong, Debbie Zittema, 2014, American Journal of Nephrology.

Vasopressin in chronic kidney disease, in particular ADPKD : Causal factor or innocent bystander?

Debbie Zittema, 2016 .

Copeptin, a surrogate marker for vasopressin, is associated with kidney function decline in subjects with autosomal dominant polycystic kidney disease.

T. Rabelink, S. Bakker, R. Gansevoort, 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Comparison of ex vivo stability of copeptin and vasopressin

R. Gansevoort, Debbie Zittema, C. Franssen, 2017, Clinical chemistry and laboratory medicine.

Urine Concentrating Capacity, Vasopressin and Copeptin in ADPKD and IgA Nephropathy Patients with Renal Impairment

S. Bakker, R. Gansevoort, Debbie Zittema, 2017, PloS one.

Urine and Plasma Osmolality in Patients with Autosomal Dominant Polycystic Kidney Disease: Reliable Indicators of Vasopressin Activity and Disease Prognosis?

S. Bakker, R. Gansevoort, E. Meijer, 2015, American Journal of Nephrology.